Welcome to our dedicated page for Rite Aid Corporation news (Ticker: RAD), a resource for investors and traders seeking the latest updates and insights on Rite Aid Corporation stock.
Rite Aid Corporation (NYSE: RAD) operates at the forefront of integrated retail pharmacy and healthcare services, providing prescription medications, wellness programs, and pharmacy benefit management solutions. This page aggregates all official announcements, financial disclosures, and strategic developments from the company.
Access real-time updates on Rite Aid's operational milestones, including earnings reports, regulatory compliance updates, and partnerships with healthcare providers. Investors will find critical filings like 10-Q and 8-K documents alongside analyses of market positioning against competitors like CVS Health and Walgreens.
The repository covers expansions in telehealth services, PBM contract renewals, and community health initiatives. Content is curated to meet the needs of stakeholders requiring timely, accurate information for decision-making.
Bookmark this page for streamlined tracking of Rite Aid's evolving role in retail healthcare. Check regularly for updates on store network changes, leadership announcements, and responses to industry trends like digital health adoption.
On March 30, 2022, Rite Aid (NYSE: RAD) announced it will administer second booster shots of the Pfizer and Moderna COVID-19 vaccines for eligible individuals, following CDC and FDA approval. Individuals aged 50 and older and certain immunocompromised individuals aged 12 and older can receive these boosters. Rite Aid has administered over 15 million COVID-19 vaccinations and encourages all eligible individuals to get vaccinated. Customers can schedule appointments online or walk in for vaccinations at approximately 2,450 locations across 17 states.
Rite Aid Corporation (NYSE: RAD) is set to release its financial results for Fiscal 2022's Fourth Quarter ending February 26, 2022, on April 14, 2022. An analyst call will follow at 8:30 a.m. Eastern Time, with management providing insights. The call will be accessible online, and listeners can access a telephone replay starting at 12 p.m. on April 14 until May 14, 2022. Rite Aid operates over 2,450 retail pharmacy locations across 17 states, emphasizing health care coordination and personalized services for families.
Rite Aid Corporation (NYSE: RAD) announced a restructuring of its management team aimed at streamlining operations and reducing costs. The changes include the elimination of the COO position, leading to the departure of Jim Peters and Jocelyn Konrad. Karen Staniforth, previously Senior VP, will now serve as Chief Pharmacy Officer. Andre Persaud will oversee field and front-end pharmacy operations. The adjustments are part of Rite Aid's strategy to enhance its pharmacy services and engage better with customers, according to CEO Heyward Donigan.
Rite Aid (NYSE:RAD) has launched Rite Aid Rewards, a new customer loyalty program enhancing shopping experiences and rewards. Members earn points for purchases and prescriptions, convert them into BonusCash, and enjoy personalized challenges. For every $1 spent, members gain 10 points, redeemable at 1,000 points for $2. The program replaces the previous wellness+ Rewards and provides members-only pricing, instant promotions, and special benefits for seniors. Current wellness+ customers are automatically enrolled, with their BonusCash remaining intact.
Bartell Drugs, a subsidiary of Rite Aid Corporation (NYSE: RAD), has partnered with Higi, a subsidiary of Babylon (NYSE: BBLN), to introduce enhanced health self-screening stations across 50 Bartell's locations in the Puget Sound area. These stations provide free assessments for various health risks, including hypertension and diabetes, and promote health awareness and education. This initiative coincides with National Heart Month and builds on a five-year partnership between Rite Aid and Higi, aimed at empowering customers to manage their health more effectively.
Rite Aid is now offering free N95 masks at many locations nationwide, with expectations to be available at most stores this week. Customers can pick up three masks each while supplies last. Additionally, Rite Aid has increased availability of at-home COVID-19 test kits, which are now reimbursable through private health insurance. The company has administered over 14 million COVID-19 vaccinations and continues to promote vaccination and booster shots as crucial in combating the pandemic.
Rite Aid Corporation (NYSE: RAD) reported a third-quarter revenue increase of 1.8% to $6.23 billion but faced a net loss of $36.1 million, or $0.67 per share, compared to a net income of $4.3 million, or $0.08 per share, last year. Adjusted EBITDA rose 12.7% to $154.8 million. The firm has initiated a store closure program, targeting 63 stores for closure, aiming for an annual EBITDA benefit of about $25 million. Due to strong momentum, Rite Aid raised its fiscal 2022 Adjusted EBITDA guidance to between $500 million and $520 million.
Rite Aid Corporation (NYSE: RAD) announced it will release its Fiscal 2022 Third Quarter financial results on December 21, 2021. An analyst call will take place at 8:30 a.m. ET, featuring management's remarks, and will be available via webcast on its investor relations website. A replay of the call will be accessible from 12:00 p.m. ET on the same day until 11:59 p.m. ET on January 21, 2022.
Rite Aid operates over 2,500 pharmacy locations across 17 states, focusing on providing affordable healthcare services.
The Rite Aid Foundation is granting
On November 2, 2021, the CDC authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for children aged 5-11, a lower-dose version intended for their safety. This vaccine is administered in a two-dose series with doses spaced three weeks apart. Rite Aid is set to begin administering these vaccines on November 6 at select locations, as doses become available. Appointments can be scheduled from November 4 via their website.
